Loading...
•
Dec 31, 2023
Thermo Fisher Q4 2023 Earnings Report
Thermo Fisher Scientific reported fourth quarter results, navigating challenging macroeconomic conditions and delivering differentiated performance.
Key Takeaways
Thermo Fisher Scientific's fourth-quarter revenue reached $10.89 billion, a 5% decrease compared to the previous year, with a core organic revenue decline of 4%. Despite the revenue dip, the company's GAAP diluted EPS rose to $4.20, and adjusted EPS increased to $5.67, both marking a 5% increase year-over-year, driven by operating margin expansion.
Fourth quarter revenue was $10.89 billion, 5% lower versus the same quarter last year.
Core organic revenue growth declined 4%.
Fourth quarter GAAP diluted EPS was $4.20, 5% higher versus the same quarter last year, driven by 70 basis points of operating margin expansion.
Fourth quarter adjusted EPS was $5.67, 5% higher versus the same quarter last year, driven by 100 basis points of adjusted operating margin expansion.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
Thermo Fisher is initiating a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.
Revenue & Expenses
Visualization of income flow from segment revenue to net income